References
- Vane J R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232–235
- Konturek S J, Obtulowicz W, Sito E, Oleksy J, Wilkon S, Kiec-Dembinska A. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: Effects of aspirin and paracetamol. Gut 1981; 22: 283–289
- Silverstein F E, Kimmey M B, Saunders D R, Levine D S. Gastric protection by misoprostol against 1300 mg of aspirin: an endoscopic study. Dig Dis Sci 1986; 31: S137–141
- Cohen M M, McGready D R, Clark L, Sevilius H. Protection against aspirin-induced antral and duodenal mucosa with enprostil. Gastroenterology 1985; 88: 382–386
- Konturek S J, Kwiecien N, Obtulowicz W, Polanski M, Kopp B, Oleksy J. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 1983; 24: 89–93
- Roth S H, Bennett R E, Mitchell C S, Hartmann R J. Cimetidine therapy in NSAID gastropathy. Double blind long-term evaluation. Arch Intern Med 1987; 147: 1798
- Rachmilewitz D, Polak D, Eliskin R, et al. Cimetidine significantly decreases indomethacin-induced gastro-duodenal mucosal damage. Gastroenterology 1986; 90: 1596
- Konturek S J, Brzozowski T, Drozdowicz D, Amon I. Nocloprost, a stable PGE2 analog with unique local gastroprotective and ulcer-healing activity. Gastroenterology 1990; 98: 70A
- Konturek S J. Role of growth factors in gastroduodenal protection and healing of peptic ulcers. Gastroenterology Clin N Am 1990; 19: 41–66
- Satzman A. A fluorometric method for the estimation of salicylate in blood. J Biol Chem 1948; 174: 399–404
- Konturek J W, Bielanski W, Konturek S J, Bogdal J, Oleksy J. Distribution and release of epidermal growth factor in man. Gut 1989; 30: 1194–1200
- Hunt J N, Fisher N A. Aspirin-induced gastric bleeding stops despite rising plasma salicylate. Dig Dis Sci 1980; 25: 135–139
- Lanza F L, Royer G L, Nelson R S, Chen T T, Seckman C E, Rack M F. The effects of ibuprofen, indomethacin, aspirin, naproxen and placebo on the gastric mucosa of normal volunteers. A gastriscopic and photographic study. Dig Dis Sci 1979; 24: 823–828
- Lanza F L, Royer G L, Nelson R S. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303: 136–138
- Douthwaite A H, Lintott G A M. Gastroscopic observation of the effect of aspirin and certain other substances in the stomach. Lancet 1938; 2: 1222–1225
- Loebl D H, Craig R M, Culic D D, Rudolfo A S, Falk J, Schmidt F R. Gastrointestinal blood loss: effect of aspirin, fenoprofen and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers. JAMA 1977; 237: 976–981
- Chernish S M, Rosenak B D, Brunelle R L, Cabtree R. Comparison of gastrointestinal effects of aspirin and fenoprofen: a double-blind crossover study. Arthritis Rheum 1979; 22: 371–375
- Ligumsky M, Golanska E M, Hansen D G, Kauffman G L. Aspirin can inhibit gastric mucosal cyclooxygenase without causing lesions in rats. Gastroenterology 1983; 84: 756–761
- Konturek S J, Radecki T, Brzozowski T, Gryglewski R. Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. Gastroenterology 1981; 81: 438–445
- Cohen M M, MacDonald W C. Mechanism of aspirin injury to human gastroduodenal mucosa. Prostaglandins Leukotrienes Med 1982; 9: 241–255
- Faust T W, Fedfern J S, Dodolsky I, Lee E, Grundy S M, Feldman M. Effects of aspirin on gastroduodenal mucosal prostaglandin E2 and F content and on gastric mucosal injury in humans receiving fish oil and olive oil. Gastroenterology 1990; 98: 586–591
- Cooke A R. The role of acid in pathogenesis of aspirin-induced gastrointestinal erosions and hemorrhage. Am J Dig Dis 1973; 18: 225–237
- Amon I. Nocloprost AH T475. Asche AG, Hamburg 1989
- Muller T A. Protective effects of prostaglandins against mucosal damage; current knowledge and proposed mechanisms. Am J Physiol 1984; 245: 601–623